Cell-induced response by tetracyclines on human bone marrow colonized hydroxyapatite and Bonelike®

Acta Biomaterialia

Volumn 4, Issue 3, 2008, Pages 630-637

  Gomes, P S ^a   Santos, J D ^b,c   Fernandes, M H ^a  

^a Portugal   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c INEB INSTITUTO DE ENGENHARIA BIOMÉDICA   (Portugal)

Author keywords

Bonelike; Hydroxyapatite; Osteoblasts; Tetracyclines

Indexed keywords

ANTIBIOTICS; BIOACTIVITY; BONE; CELL PROLIFERATION; OSTEOBLASTS; TISSUE CULTURE;

BACTERIAL INFECTIONS; BONE DEFECT; BONE DISEASE; BONELIKE; CLINICAL OUTCOME; DOXYCYCLINE; HUMAN BONE MARROW; MINOCYCLINE; THERAPEUTIC AGENTS; TISSUE FORMATION;

HYDROXYAPATITE;

ALKALINE PHOSPHATASE BONE ISOENZYME; CALCIUM PHOSPHATE; DOXYCYCLINE; GLASS; HYDROXYAPATITE; MINOCYCLINE; TETRACYCLINE DERIVATIVE;

ADULT; ANTIMICROBIAL ACTIVITY; ARTICLE; BONE INFECTION; BONE MARROW CELL; CELL CULTURE; CELL FUNCTION; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IMPLANT; OSTEOBLAST; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; STROMA CELL;

BACTERIA (MICROORGANISMS);

EID: 41549100057     PISSN: 17427061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actbio.2007.12.006     Document Type: Article

References (58)

1. Chambers H. Protein synthesis inhibitors and miscellaneous antibacterial agents. In: Brunton L. (Ed). Goodman and Gilman's - The Pharmacological Basis of Therapeutics (2006), McGraw-Hill, Germany 1173-1202
2. Alkan A., Erdem E., Gunhan O., and Karasu C. Histomorphometric evaluation of the effect of doxycycline on the healing of bone defects in experimental diabetes mellitus: a pilot study. J Oral Maxillofac Surg 60 (2002) 898
3. TM). Brit J Oral Maxillofacial Surg 42 (2004) 452-456
4. Ramamurthy N., Rifkin B., Greenwald R., Xu J.-W., Liu Y., Turner G., et al. Inhibition of matrix metalloproteinase-mediated periodontal bone loss in rats: a comparison of 6 chemically modified tetracyclines. J Periodontol 73 (2005) 726-734
5. Golub L., Ramamurthy N., Kaneko H., Sasaki T., Rifkin B., and McNamara T. Tetracycline administration prevents diabetes-induced osteopenia in the rat: initial observations. Res Commun Chem Pathol Pharmacol 68 (1990) 27
6. Williams S., Wakisaka A., Zeng Q., Barnes J., Martin G., and Wechter W. Minocycline prevents the decrease in bone mineral density and trabecular bone in ovariectomized aged rats. Bone 19 (1996) 637-644
7. Williams S., Wakisaka A., Zeng Q., Barnes J., Seyedin S., Martin G., et al. Effect of minocycline on osteoporosis. Adv Dental Res 12 (1998) 71-75
8. Pytlik M., Folwarczna J., and Janiec W. Effects of doxycycline on mechanical properties of bones in rats with ovariectomy-induced osteopenia. Calcified Tissue Int 75 (2004) 225-230
9. Holmes S., Still K., Buttle D., Bishop N., and Grabowski P. Chemically modified tetracyclines act through multiple mechanisms directly on osteoclast precursors. Bone 35 (2004) 471-478
10. Polson A., Bouwsma O., McNamara T., and Golub L. Enhancement of alveolar bone formation after tetracycline administration in squirrel monkeys. J Appl Res Clin Dent (2005) 32-42
11. Yamaguchi A., Udagawa T., and Sawai T. Transport of divalent cations with tetracycline as mediated by the transposon Tn10-encoded tetracycline resistance protein. J Biol Chem 265 (1990) 4809-4813
12. Li S., de Wijn J., Layrolle P., and de Groot K. Synthesis of macroporous hydroxyapatite scaffolds for bone tissue engineering. J Biomed Mater Res 61 (2002) 109-120
13. Giannoudis P., Dinopoulos H., and Tsiridis E. Bone substitutes: an update. Int J Care Injured 365 (2005) 220
14. LeGeros R. Properties of osteoconductive biomaterials: calcium phosphates. Clin Orthop 395 (2002) 81-98
15. Suchanek W., and Yoshimura M. Processing and properties of hydroxyapatite-based biomaterials for use as hard tissue replacement implants. J Mater Res 13 (1998) 94-117
16. Lopes M., Santos J., Monteiro F., and Knowles J. Glass reinforced hydroxyapatite: a comprehensive study of the effect of glass composition on the crystallography of the composite. J Biomed Mater Res 39 (1998) 244-250
17. Hench L. Bioactive materials: the potential for tissue regeneration. J Biomed Mater Res 41 (1998) 511-518
18. Kellomaki M., Niiranen H., Puumanen K.A.N., Waris T., and Tormala P. Bioabsorbable scaffolds for guided bone, regeneration, and generation. Biomaterials 21 (2000) 2495-2505
19. Santos J., Reis R., Monteiro F., Knowles J., and Hastings G. Liquid phase sintering of hydroxyapatite by phosphate and silicate glass additions structure and properties of the composites. J Mater Sci Mat Med 6 (1995) 348
20. 2O and MgO. J Mater Sci Mat Med. 7 (1996) 187
21. Duarte F., Santos J., and Afonso A. Medical applications of Bonelike in maxillofacial surgery. Mater Sci Forum 370 (2004) 455-456
22. ® graft implanted in the tibia of humans. Key Eng Mater 1041 (2005) 284-286
23. Brause B. Infections with prostheses in bones and joints. In: Mandell G., Bennet J., and Dolin R. (Eds). Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases. 5th ed. (2000), Churchill Livingstone, Philadelphia 1196-1200
24. Darley E., and MacGowan A. Antibiotic treatment of Gram-positive bone and joint infections. J Antimicrobial Chemotherapy 53 (2004) 928-935
25. Zucchelli G., Sforza N., Clauser C., Cesari C., and De Sanctis M. Topical and systemic antimicrobial therapy in guided tissue regeneration. J Periodontol 70 (1999) 239-247
26. Yukna R., and Sepe W. Clinical evaluation of localized periodontosis defects treated with freeze-dried bone allografts combined with local and systemic tetracyclines. Int J Periodontics Restorative Dent 2 (1982) 8-21
27. Shirtliff M., and Mader J. Acute septic arthritis. Clin Microbiol Rev 15 (2002) 527-544
28. Sunder M., Babu N., Victor S., Kumar K., and Kumar T. Biphasic calcium phosphates for antibiotic release. Trends Biomater Artif Organs 18 (2005) 213-218
29. Lieberman J., Daluiski A., and Einhorn T. The role of growth factors in the repair of bone: biology and clinical applications. J Bone Joint Surg 84 (2002) 1032-1044
30. Carson J., and Bostrom M. Synthetic bone scaffolds and fracture repair. Injury 38 (2007) S33-S70
31. Regí-Vallet M., Balas F., Colilla M., and Manzano M. Drug confinement and delivery in ceramic implants. Drug Metabol Lett 1 (2007) 37-40
32. Lin T.-L., Lu F.-M., Conroy S., Sheu M.-S., Su S.-H., and Tang L. Antimicrobial coatings: a remedy for medical device-related infections. Med Device Technol. 12 (2001) 26-30
33. Beardmore A., Brooks D., Wenke J., and Thomas D. Effectiveness of local antibiotic delivery with an osteoinductive and osteoconductive bone-graft substitute. J Bone Joint Surg 87 (2005) 107-112
34. Gomes P., and Fernandes M. Effect of therapeutic levels of doxycycline and minocycline in the proliferation and differentiation of human bone marrow osteoblastic cells. Arch Oral Biol 52 (2007) 251-259
35. Coelho M., and Fernandes M. Human bone cell cultures in biocompatibility testing Part II. Effect of ascorbic acid, β-glycerophosphate and dexamethasone on osteoblastic differentiation. Biomaterials 21 (2000) 1095-1102
36. Jørgensen N., Henriksena Z., Sørensena O., and Civitelli R. Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts. Steroids 69 (2004) 219-226
37. Sakellari D., Goodson J., Socransky S., Kolokotronis A., and Konstantinidis A. Concentration of 3 tetracyclines in plasma, gingival crevice fluid and saliva. J Clin Periodontol 27 (2000) 53-60
38. Stein G., and Lian J. Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype. Endocr Rev 14 (1993) 424-442
39. 5 Glass ceramics containing bioactive phases: crystallization and in vitro bioactivity studies. Key Eng Mater 192 (2001) 643-646
40. 5-glass reinforced hydroxyapatite on the growth and function of osteoblast-like cells. Biomaterials 21 (2000) 1165-1172
41. Costa M., Gutierres M., Almeida L., Lopes M., Santos J., and Fernandes M. In vitro mineralisation of human bone marrow cells cultured on Bonelike. Key Eng Mater (2004) 254-256 (821-4)
42. Lopes M., Santos J., Monteiro F., Ohtsuki C., Osaka A., Kaneko S., et al. Push-out testing and histological evaluation of glass reinforced hydroxyapatite composites implanted in the tibia of rabbits. J Biomed Mater Res 54 (2001) 463-469
43. ® synthetic bone graft. J Ortho Res 24 (2006) 953
44. Kima H.-W., Leea E.-J., Kima H.-E., Salihb V., and Knowles J. Effect of fluoridation of hydroxyapatite in hydroxyapatite-polycaprolactone composites on osteoblast activity. Biomaterials 26 (2005) 4395-4404
45. Williams S., Barnes J., Wakisaka A., Ogasa H., and Liang C. Treatment of osteoporosis with MMP inhibitors. Ann NY Acad Sci 878 (1999) 191-200
46. Schwartz Z., Lohmann C., Wieland M., Cochran D., Dean D., Textor M., et al. Osteoblast proliferation and differentiation on dentin slices are modulated by pretreatment of the surface with tetracycline or osteoclasts. J Periodontol 71 (2000) 586-597
47. Bettany J., and Wolowacz R. Tetracycline derivatives induce apoptosis selectively in cultured monocytes and macrophages but not in mesenchymal cells. Adv Dent Res 12 (1998) 136-143
48. Duewelhenke N., Krut O., and Eysel P. Influence on mythochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines. Antimicrobial Agents and Chemotherapy 51 (2007) 54-63
49. Golub L., Wolff M., Roberts S., Lee H.-M., Leung M., and Payonk G. Treating periodontal diseases by blocking tissue-destructive enzymes. JADA 125 (1994) 163-169
50. Woessner J., and Nagase H. Inhibition of MMPs. In: Woessner J., and Nagase H. (Eds). MMPs and Timps (2000), Oxford University Press, Oxford 109-125
51. Golub L., Ramamurthy N., McNamara T., Gomes B., Wolff M., Casino A., et al. Tetracyclines inhibit tissue collagenase activity. A new mechanism in the treatment of periodontal disease. J Periodontal Res 19 (1984) 651-655
52. Yu Z., Ramamurthy N., Leung M., Chang K., McNamara T., and Golub L. Chemically-modified tetracycline normalizes collagen metabolism in diabetic rats: a dose-response study. J Periodontal Res 28 (1993) 420-428
53. Karimbux N., Ramamurthy N., Golub L., and Nishimura I. The expression of collagen I and XII on RNAs in porphyromonas gingivalis-induced periodontitis in rats: The effect of doxycycline and chemically-modified tetracycline (CMT-1). J Periodontol 69 (1998) 39-40
54. Ramamurthy N., Pirila E., and Lee H.-M. Delayed wound healing, altered collagen level and keratinocyte growth factor expression in skin of ovariectomized rat is normalized by estrogen or chemically modified doxycycline. In: Schneider H. (Ed). Menopause - The State of the Art in Research and Management. The Proceedings of the Tenth World Congress (2003), Parthenon Publishing Group, New York 236-243
55. 1 levels in severe, generalized chronic periodontitis. J Clin Periodontol 32 (2005) 244-253
56. Caton J. Evaluation of Periostat for patient management. Compend Contin Edu Dent 20 (1999) 451-456
57. Salasznyk R., Williams W., Boskey A., Batorsky A., and Plopper G. Adhesion to vitronectin and collagen I promotes osteogenic differentiation of human mesenchymal stem cells. J Biomed Biotechnol 1 (2004) 24-34
58. Gerstenfeld L., Chipman S., Kelly C., Hodgens K., Lee D., and Landis W. Collagen expression, ultrastructural assembly, and mineralization in cultures of chicken embryo osteoblasts. J Cell Biol 106 (1988) 979-989